More about Vijaya Diagnostic Centre Limited
Fundamentals for Vijaya Diagnostic Centre Limited
Regulatory Filings for Vijaya Diagnostic Centre Limited
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
Fundamentals for Vijaya Diagnostic Centre Limited
Business Operations:
Sector: HealthcareIndustry: Diagnostics & Research
Vijaya Diagnostic Centre Limited engages in the provision of diagnostic services for patients in India. It offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. The company also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
Revenue projections:
With VIJAYA's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.
Financial Ratios:
| currentRatio | 0.00000 |
|---|---|
| forwardPE | 51.86562 |
| debtToEquity | 42.22400 |
| earningsGrowth | 0.22500 |
| revenueGrowth | 0.21400 |
| grossMargins | 0.84993 |
| operatingMargins | 0.30074 |
| trailingEps | 15.45000 |
| forwardEps | 20.54444 |
VIJAYA's forward PE is elevated, which could constrain price appreciation and lead to a correction. Investors should consider this parameter in conjunction with other fundamentals to fully assess whether the stock is priced fairly.
Positive earnings and revenue growth for VIJAYA suggest that the company is positioned for business expansion. The company's strong financial performance indicates sustained growth, as increasing sales and profits fuel its future success.
VIJAYA's positive gross and operating margins reflect its profitability and efficiency. These metrics demonstrate the company's ability to manage costs effectively while generating strong revenue, highlighting its solid financial health and operational effectiveness.
VIJAYA's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights VIJAYA's potential for increased earnings and a stronger financial performance in the upcoming year.
Price projections:
Vijaya Diagnostic Centre Limited's price has consistently hovered around the lower limit of price projections. This pattern suggests that the stock may be underperforming relative to expectations, which could lead to concerns among investors.
Recommendation changes over time:
A recent buy bias from analysts toward Vijaya Diagnostic Centre Limited may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that Vijaya Diagnostic Centre Limited might be an appealing option for those looking to grow their wealth through stock market investments.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy
The Hidden Engine of Global Growth: Why India Is Becoming Impossible to Overlook
₹10,000 Crore Deep-Tech Pivot: Why Fund of Funds 2.0 Will Redraw India's Startup Map